This product is in stock，please ask for price.
If you have any question, please send the email to sales@xmobio.com for the availability.We will reply to you as soon as possible.
Shipment: Products are shipped via FedEx Express. |
|
| Description |
| INCB39110 or INCB039110 is a potent JAK1 tyrosine kinase inhibitor, which is currently in Phase II trials for the treatment of rheumatoid arthritis, myelofibrosis, rheumatoid arthritis and plaque psoriasis. INCB039110 produced significant improvements in sPGA, demonstrating proof of concept in chronic plaque psoriasis. |
| Chemical Structure |
 |
| Chemical Name |
| 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile |
| SMILES Code |
| N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(C5CCN(C(C6=C(F)C(C(F)(F)F)=NC=C6)=O)CC5)C1 |
| Theoretical Analysis |
XingMo Cat#:XM101
Product Name:Itacitinib (INCB039110)
Synonyms:INCB39110; INCB 39110; INCB-39110; INCB039110; INCB-039110; INCB 039110; Itacitinib; 1334298-96-2
CAS#:1334298-90-6
Chemical Formula:C26H23F4N9O
Exact Mass:553.1962
Molecular Weight:553.51
|
| Technical Data |
WARNING: This product is for research use only, not for human or veterinary use
|
|
|
